Health Technology Assessment (HTA)

All Services

Health Technology Assessment (HTA)

Health Technology Assessment (HTA) is a structured evaluation of the clinical, economic, and societal value of health technologies—including pharmaceuticals, medical devices, diagnostics, and digital health solutions. The goal is to support evidence‑based decisions on pricing, reimbursement, and adoption within the healthcare system. HTA integrates clinical evidence, cost‑effectiveness, budget impact, and real‑world considerations to guide policy and market access strategies.

What We Offer
  • HTA Dossier Development aligned with national and international requirements
  • Clinical & Economic Evidence Review including systematic literature reviews
  • Cost‑Effectiveness & Budget Impact Analyses tailored to local healthcare settings
  • Value Proposition & Evidence Strategy Development
  • Model Adaptation for Local Context (epidemiology, pricing, resource use)
  • Stakeholder‑Ready Reports & Value Communication Materials
  • Advisory Support for Pricing, Reimbursement, and Market Access Submissions
Who Benefits from This Service
  • Pharmaceutical & Biotech Companies
  • Medical Device & Digital Health Companies
  • Payers & Regulators
  • Hospitals & Healthcare
  • Policy Makers & Public Health Agencies
  • Investors & Health Innovators